The so-called Netflix payment model for obtaining hepatitis C treatments appears to be catching on among state officials as a Washington state health agency is the latest one hoping to convince drug makers to participate in such a scheme.

The state Health Care Authority late last month began soliciting bids from drug makers to provide a guaranteed net unit price for Medicaid beneficiaries, and a similarly low price for other state employees. The goal is to eradicate the chronic disease from these groups by 2030 and to lower spending that last year reached about $80 million.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy